Bruno Carvalho Menarim

Dr. Bruno Carvalho Menarim

orcid

Research Focus & Metrics

Representative Publications

View All Publications
1 December 2014 in Cryobiology
Verified
Journal Article
Closed access
ACAlex Córdova
Alex Córdova
PSPablo Strobel
Pablo Strobel
AVAndrés Vallejo
Andrés Vallejo
PVPamela Valenzuela
Pamela Valenzuela
OUOmar Ulloa
Omar Ulloa
ARAlfredo Ramirez
Alfredo Ramirez

30 October 2019 in The FASEB Journal
Verified
Journal Article
Open access
PDF file
BMBruno Carvalho Menarim
Bruno Carvalho Menarim
KGKiersten H. Gillis
Kiersten H. Gillis
AOAndrea Oliver
Andrea Oliver
CMCaitlin Mason
Caitlin Mason
YNYing Ngo
Ying Ngo
LDLinda A. Dahlgren
Linda A. Dahlgren
Osteoarthritis (OA) is characterized by macrophage‐driven synovitis. Macrophages promote synovial health but become inflammatory when their regulatory functions are overwhelmed. Bone marrow mononuclear cells (BMNCs) are a rich source of macrophage progenitors used for treating chronic inflammation and produce essential molecules for cartilage metabolism. This study investigated the response to autologous BMNC injection in normal and inflamed joints. Synovitis was induced in both radiocarpal joints of 6 horses. After 8 h, 1 inflamed radiocarpal and 1 normal tarsocrural joint received BMNC injection. Contralateral joints were injected with saline. Synovial fluid was collected at 24, 96, and 144 h for cytology, cytokine quantification, and flow cytometry. At 144 h, horses were euthanatized, joints were evaluated, and synovium was harvested for histology and immunohistochemistry. Four days after BMNC treatment, inflamed joints had 24% higher macrophage counts with 10% more IL‐10 + cells than saline‐treated controls. BMNC‐treated joints showed gross and analytical improvements in synovial fluid and synovial membrane, with increasing regulatory macrophages and synovial fluid IL‐10 concentrations compared with saline‐treated controls. BMNC‐treated joints were comparable to healthy joints histologically, which remained abnormal in saline‐treated controls. Autologous BMNCs are readily available, regulate synovitis through macrophage‐associated effects, and can benefit thousands of patients with OA.—Menarim, B. C., Gillis, K.H., Oliver, A., Mason, C., Ngo, Y., Werre, S.R., Barrett, S.H., Luo, X., Byron, C.R., Dahlgren, L. A. Autologous bone marrow mononuclear cells modulate joint homeostasis in an equine in vivo model of synovitis. FASEB J. 33, 14337‐14353 (2019). www.fasebj.org

6 February 2020 in The FASEB Journal
Verified
Journal Article
Open access
PDF file
BMBruno Carvalho Menarim
Bruno Carvalho Menarim
KGKiersten H. Gillis
Kiersten H. Gillis
AOAndrea Oliver
Andrea Oliver
CMCaitlin Mason
Caitlin Mason
SWStephen R. Werre
Stephen R. Werre
LDLinda A. Dahlgren
Linda A. Dahlgren
Synovial inflammation is a central feature of osteoarthritis (OA), elicited when local regulatory macrophages (M2‐like) become overwhelmed, activating an inflammatory response (M1‐like). Bone marrow ...

26 July 2021 in World Journal of Stem Cells
Verified
Journal Article
Open access
BMBruno Carvalho Menarim
Bruno Carvalho Menarim
JMJames N MacLeod
James N MacLeod
LDLinda A Dahlgren
Linda A Dahlgren
Bone marrow mononuclear cells for joint therapy: The role of macrophages in inflammation resolution and tissue repair

8 December 2021 in Frontiers in Immunology
Verified
Journal Article
Open access
BMBruno Carvalho Menarim
Bruno Carvalho Menarim
Hossam El-Sheikh AliHossam El-Sheikh Ali
Hossam El-Sheikh Ali
SLShavahn C. Loux
Shavahn C. Loux
Kirsten E ScogginKirsten E Scoggin
Kirsten E Scoggin
TKTheodore S. Kalbfleisch
Theodore S. Kalbfleisch
LDLinda A. Dahlgren
Linda A. Dahlgren
Osteoarthritis (OA) may result from impaired ability of synovial macrophages to resolve joint inflammation. Increasing macrophage counts in inflamed joints through injection with bone marrow mononuclear cells (BMNC) induces lasting resolution of synovial inflammation. To uncover mechanisms by which BMNC may affect resolution, in this study, differential transcriptional signatures of BMNC in response to normal (SF) and inflamed synovial fluid (ISF) were analyzed. We demonstrate the temporal behavior of co-expressed gene networks associated with traits from relatedin vivoandin vitrostudies. We also identified activated and inhibited signaling pathways and upstream regulators, further determining their protein expression in the synovium of inflamed joints treated with BMNC or DPBS controls. BMNC responded to ISF with an early pro-inflammatory response characterized by a short spike in the expression of a NF-ƙB- and mitogen-related gene network. This response was associated with sustained increased expression of two gene networks comprising known drivers of resolution (IL-10, IGF-1, PPARG, isoprenoid biosynthesis). These networks were common to SF and ISF, but more highly expressed in ISF. Most highly activated pathways in ISF included the mevalonate pathway and PPAR-γ signaling, with pro-resolving functional annotations that improve mitochondrial metabolism and deactivate NF-ƙB signaling. Lower expression of mevalonate kinase and phospho-PPARγ in synovium from inflamed joints treated with BMNC, and equivalent IL-1β staining between BMNC- and DPBS-treated joints, associates with accomplished resolution in BMNC-treated joints and emphasize the intricate balance of pro- and anti-inflammatory mechanisms required for resolution. Combined, our data suggest that BMNC-mediated resolution is characterized by constitutively expressed homeostatic mechanisms, whose expression are enhanced following inflammatory stimulus. These mechanisms translate into macrophage proliferation optimizing their capacity to counteract inflammatory damage and improving their general and mitochondrial metabolism to endure oxidative stress while driving tissue repair. Such effect is largely achieved through the synthesis of several lipids that mediate recovery of homeostasis. Our study reveals candidate mechanisms by which BMNC provide lasting improvement in patients with OA and suggests further investigation on the effects of PPAR-γ signaling enhancement for the treatment of arthritic conditions.

1 April 2012 in Journal of Equine Veterinary Science
Verified
Journal Article
Closed access
BMBruno Carvalho Menarim
Bruno Carvalho Menarim
VMVânia Maria Vasconcelos Machado
Vânia Maria Vasconcelos Machado
LALuís Emiliano Cisneros Alvarez
Luís Emiliano Cisneros Alvarez
RCRodrigo Carneiro
Rodrigo Carneiro
LBLeandro Busch
Leandro Busch
LVLuiz Carlos Vulcano
Luiz Carlos Vulcano